Modeling features of autism in animals

Understanding Autism: From Basic Neuroscience to Treatment

Volumn , Issue , 2006, Pages 277-302

  Patterson, Paul H ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 69249221171     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (181)

1. Bauman, M.L. and Kemper, T.L., Neuroanatomic observations of the brain in autism: a review and future directions, Int. J. Dev. Neurosci., 23, 183, 2005.
2. Belmonte, M.K. et al., Autism as a disorder of neural information processing: directions for research and targets for therapy, Mol. Psychiatry, 9, 1, 2004.
3. Hornig, M. and Lipkin, W.I., Infectious and immune factors in the pathogenesis of neurodevelopmental disorders: epidemiology, hypotheses, and animal models, Ment. Retard. Dev. Disabil. Res. Rev., 7, 200, 2001.
4. Ashwood, P. and Van de Water, J., A review of autism and the immune response, Clin. Dev. Immunol., 11, 165, 2004.
5. Bartlett, C.W., Gharani, N., Millonig, J.H., and Brzustowicz, L.M., Three autism candidate genes: a synthesis of human genetic analysis with other disciplines, Int. J. Dev. Neurosci., 23, 221, 2005.
6. Muhle, R., Trentacoste, S.V., and Rapin, I., The genetics of autism, Pediatrics, 113, 472, 2004.
7. Andres, C., Molecular genetics and animal models in autistic disorder, Brain Res. Bull., 57, 109, 2002.
8. Pearce, B.D., Modeling the role of infections in the etiology of mental illness, Clin. Neurosci. Res., 3, 271, 2003.
9. Keller F. and Perisco, A.M., The neurobiological context of autism, Mol. Neurobiol., 28, 1, 2003.
10. Murcia, C.L., Gulden, F., and Herrup, K., A question of balance: a proposal for new mouse models of autism, Int. J. Dev. Neurosci., 23, 265, 2005.
11. Wassink, T.H., Pivan, J., and Patil, S.R., Chromosomal abnormalities in a clinic sample of individuals with autistic disorder, Psychiatr. Genet., 11, 57, 2001.
12. Miyashiro, K.Y. et al., RNA cargoes associating with FMRP reveal deficits in cellular functioning in FMR1 null mice, Neuron, 37, 417, 2003.
13. Bear, M.F., Huber, K.M., and Warren, S.T., The mGluR theory of fragile X mental retardation, Trends Neurosci., 27, 369, 2004.
14. Kooy, R.F. et al., Transgenic mouse model for the fragile X syndrome, Am. J. Med. Genet., 64, 241, 1996.
15. D’ Hooge, R. et al., Mildly impaired water maze performance in male Fmr1 knockout mice, Neuroscience, 76, 367, 1997.
16. Oostra, B.A. and Hoogeveen, A.T., Animal model for fragile X syndrome, Ann. Med., 29, 563, 1997.
17. Peier, A.M. et al., (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features, Hum. Mol. Genet., 9, 1145, 2000.
18. Comery, T.A. et al., Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits, Proc. Natl. Acad. Sci. USA, 94, 5401, 1997.
19. Galvez, R., Gopal, A.R., and Greenough, W.T., Somatosensory cortical barrel dendritic abnormalities in a mouse model of the fragile X mental retardation syndrome, Brain Res., 1, 83, 2003.
20. Irwin, S.A. et al., Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination, Am. J. Med. Genet., 98, 161, 2001.
21. Raymond, G.V., Bauman, M.L., and Kemper T.L., Hippocampus in autism: a Golgi analysis, Acta. Neuropathol., 91, 117, 1996.
22. Jamain, S. et al., Paris Autism Research International Sibpair Study, Mutations of the x-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism, Nat. Genet., 34, 27, 2003.
23. Laumonnier, R. et al., X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family, Am. J. Hum. Genet., 74, 552, 2004.
24. Chih, B., Shehla, K.A., Clark, L., and Scheiffele, P., Disorder-associated mutations lead to functional inactivation of neuroligins, Hum. Mol. Genet., 13, 1474, 2004.
25. Comoletti, D. et al., The Arg451Cys-Neuroligin-3 mutation associated with autism reveals a defect in protein processing, J. Neurosci., 24, 4889, 2004.
26. Kattenstroth, G. et al., Postsynaptic N-methyl-D-aspartate receptor function requires α-neurexins, Proc. Natl. Acad. Sci. USA, 101, 2607, 2003.
27. Glaze, D.G., Rett syndrome: of girls and mice - lessons for regression in autism, Ment. Retard. Dev. Disabil. Res. Rev., 10, 154, 2004.
28. Neul, J.L. and Zoghbi, H.Y., Rett syndrome: a prototypical neurodevelopmental disorder, Neuroscientist, 10, 118, 2004.
29. Shahbazian, M. et al., Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3, Neuron, 35, 243, 2002.
30. Jiang, Y.H. and Beaudet, A.L., Human disorders of ubiquitination and proteasomal degradation, Curr. Opin. Pediatr., 16, 419, 2004.
31. Jiang, Y.H. et al., Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation, Neuron, 21, 799, 1998.
32. Weeber, E.J. and Sweatt, J.D., Molecular neurobiology of human cognition, Neuron, 33, 845, 2002.
33. Fombonne, E., Prevalence of childhood disintegrative disorder, Autism, 6, 149, 2002.
34. Blatt, G.J. et al., Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study, J. Autism Dev. Disord., 31, 537, 2001.
35. Homanics, G.E. et al., Mice devoid of γ-aminobutyrate type A receptor β 3 subunit have epilepsy, cleft palate, and hypersensitive behavior, Proc. Natl. Acad. Sci. USA, 94, 4143, 1997.
36. A receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome, J. Neurosci., 18, 8505, 1996.
37. Lim, M.M., Bielsky, I.F., and Young, L.J., Neuropeptides and the social brain: potential rodent models of autism, Int. J. Dev. Neurosci., 23, 235, 2005.
38. Winslow, J.T., Neuropeptides and non-human primate social deficits associated with pathogenic rearing experience, Int. J. Dev. Neurosci., 23, 245, 2005.
39. Modahl, C. et al., Plasma oxytocin levels in autistic children, Biol. Psychiatry, 43, 270, 1998.
40. Green, L.A. et al., Oxytocin and autistic disorder: alterations in peptide forms, Biol. Psychiatry, 50, 609, 2001.
41. Hollander, E. et al., Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders, Neuropsychopharmacology, 28, 193, 2003.
42. Ferguson, J.N. et al., Social amnesia in mice lacking the oxytocin gene, Nat. Genet., 25, 284, 2000.
43. Gernsbacher, M.A. et al., Autism and deficits in attachment behavior, Science, 307, 1201, 2005.
44. Ferguson, J.N., Aldag, J.M., Insei, T.R., and Young, L.J., Oxytocin in the medial amygdala is essential for social recognition in the mouse, J. Neurosci., 21, 8278, 2001.
45. Kim, S.J. et al., Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism, Mol. Psychiatry, 7, 503, 2002.
46. Bielsky, I.F. et al., Profound impairment in social recognition and reduction in anxietylike behavior in vasopressin VIa receptor knockout mice, Neuropharmacology, 29, 483, 2004.
47. Engelmann, M. and Landgraf, R., Microdialysis administration of vasopressin into the septum improves social recognition in Brattelboro rats, Physiol. Behav., 55, 145, 1994.
48. Feifel, D., Melendez, G., and Shilling, P.D., Reversal of sensimotor gating deficits in Brattelboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects, Neuropsychopharmacology, 29: 731, 2004.
49. Cook, E.H., Jr. and Leventhal, B.L., The serotonin system in autism, Curr. Opin. Pediatr., 4, 348, 1996.
50. Anderson, G.M. et al., Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia, Mol. Psychiatry, 7, 831, 2002.
51. Mulder., E.J. et al., Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates, J. Am. Acad. Child Adolesc. Psychiatry, 43, 491, 2004.
52. Chugani, D.C. et al., Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys, Ann. Neurol., 42, 666, 1997.
53. Chugani, D.C. et al., Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children, Ann. Neurol., 45, 287, 1999.
54. Chandana, S.R. et al., Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism, Int. J. Dev. Neurosci., 23, 171, 2005.
55. Hollander, E., Phillips, A.T., Chaplin, W., Zaqursky, K., Novotny, S., and Iyengar, R., A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism, Neuropsychopharmacology, 30, 582, 2005.
56. Whitaker-Azmitia, P.W., Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?, Int. J. Dev. Neurosci., 23, 75, 2005.
57. Gaspar, P., Cases, O., and Maroteaux, L., The developmental role of serotonin: news from mouse molecular genetics, Nat. Rev. Neurosci., 4, 1002, 2003.
58. Yan, W., Wilson, C.C., and Haring, J.H., Effects of neonatal serotonin depletion on the development of rat dentate granule cells, Dev. Brain Res., 98, 177, 1997.
59. Raymond, G.V., Bauman, M.L., and Kemper, T.L., Hippocampus in autism: a Golgi analysis, Acta. Neuropathol. (Berl), 91, 117, 1996.
60. Lauder, J.M., and Krebs, H., Serotonin as a differentiation signal in early embryogenesis, Dev. Neurosci., 1, 15, 1978.
61. Kahne, D. et al., Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism, Physiol. Behav., 75, 403, 2002.
62. Fatemi, S.H. et al., Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum, J. Autism Dev. Disord., 31, 529, 2001.
63. Casanova, M.F. et al., Minicolumnar pathology in autism, Neurology, 58, 428, 2002.
64. Casanova, M.F., White matter volume increase and minicolumns in autism, Ann. Neurol., 56, 453, 2004.
65. Connell, S., Karikari, C. and Hohmann, D.F., Sex-specific development of cortical monamine levels in mouse, Brain Res. Dev. Brain Res., 151, 187, 2004.
66. Gingrich, J.A. et al., New lessons from knockout mice: the role of serotonin during development and its possible contribution to the origins of neuropsychiatric disorders, CNS Spectr., 8, 572, 2003.
67. Luo, X.P.A.L.J., Serotonergic regulation of somatosensory cortical development: lessons from genetic mouse models, Dev. Neurosci., 25, 173, 2003.
68. Tierney, E. et al., Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome, Am. J. Med. Genet., 98, 191, 2001.
69. Kelley, R.I. and Hennekam, R.C., The Smith-Lemli-Opitz syndrome, J. Med. Genet., 37, 321, 2000.
70. Waage-Baudet, H. et al., Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: implications for autism, Int. J. Dev. Neurosci., 21, 451, 2003.
71. Turner, G. et al., Variable expression of mental retardation, autism, seizures, and dystonic hand movements in two families with an identical ARX gene mutation, Am. J. Med. Genet., 112, 405, 2002.
72. Stromme, P. et al., Infantile spasms, dystonia, and other X-linked phenotypes caused by mutations in Aristaless related homeobox gene, ARX, Brain Dev., 24, 266, 2002.
73. Stuhmer, T. et al., Ectopic expression of the Dlx genes induces glutamic acid decarboxylase and Dlx expression, Development, 129, 245, 2002.
74. Petit, E. et al., Association study with two markers of a human homeogene in infantile autism, J. Med. Genet., 32, 269, 1995.
75. Gharani, N. et al., Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder, Mol. Psychiatry, 9, 474, 2004.
76. Courchesne, E., Redcay, E., and Kennedy, D.P., The autistic brain: birth through adulthood, Curr. Opin. Neurol., 17, 489, 2004.
77. Liu, A.M. and Joyner, A.L., Early anterior/posterior patterning of the midbrain and cerebellum, Annu. Rev. Neurosci., 24, 869, 2001.
78. Bailey, A. et al., A clinicopathological study of autism, Brain, 121, 889, 1998.
79. Kuemerle, B. et al., Pattern deformities and cell loss in Engrailed-2 mutant mice suggest two separate patterning events during cerebellar development, J. Neurosci., 17, 7881, 1997.
80. Kuemerle, B., Williams, E.A., and Herrup, K., The engrailed-2 mutant as a model of the neuropathology of autism, Program No. 116.9, Abstract Viewer/Itinerary Planner, Washington, D.C.: Society for Neuroscience, 2004.
81. Lee, M. et al., Nicotinic receptor abnormalities in the cerebellar cortex in autism, Brain, 125, 1483 2002.
82. Perry, E.K. et al., Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain, Am. J. Psychiatry, 158, 1058, 2001.
83. Martin-Ruiz, C.M. et al., Molecular analysis of nicotinic receptor expression in autism, Brain Res. Mol. Brain Res., 123, 81, 2004.
84. Hardan, A.Y. and Handen, B.L., A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder, J. Child Adolesc. Psychopharmacol., 12, 237, 2002.
85. Marubio, L.M. et al., Reduced antinociception in mice lacking neuronal nicotinic receptor subunits, Nature, 398, 805, 1999.
86. Picciotto, M.R., Brunzell, D.H., and Caldarone, B.J., Effect of nicotine and nicotinic receptors on anxiety and depression, Neuroreport, 13, 1097, 2002.
87. Long, J.M et al., Expanded characterization of the social interaction abnormalities in mice lacking Dvl1, Genes Brain Behav., 3, 51, 2004.
88. Li. J. et al., Lack of evidence for an association between WNT2 and RELN polymorphisms and autism, Am. J. Med. Genet. B Neuropsychiatr. Genet., 126, 51, 2004.
89. Panksepp, J., A neurochemical theory of autism, Trends Neurosci., 2, 174, 1989.
90. Nelson, E.E. and Panksepp, J., Brain substrates of infant-mother attachment: contributions of opioids, oxytocin, and norepinephrine, Neurosci. Biobehav. Rev., 22, 437, 1998.
91. Moles, A., Kieffer, B.L., and D’Amato, F.R., Deficit in attachment behavior in mice lacking the µ-opioid receptor gene, Science, 304, 1983, 2004.
92. Nader, R. et al., Expression of pain in children with autism, Clin. J. Pain, 20, 88, 2004.
93. Mason, G., Stereotypies: a critical review, Anim. Behav., 41, 1015, 1991.
94. Turner, C.A. et al., Spontaneous stereotypy in an animal model of Down syndrome: Ts65Dn mice, Behav. Genet., 31, 393, 2001.
95. Presti, M.F., Gibney, B.C., and Lewis, M.H., Effects of intrastriatal administration of selective dopaminergic ligands on spontaneous stereotypy in mice, Physiol. Behav., 80, 433, 2004.
96. Turner, C.A. and Lewis, M.H., Environmental enrichment: effects on stereotyped behavior and neurotrophin levels, Physiol. Behav., 80, 259, 2003.
97. Persico, A.M. et al., Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder, Mol. Psychiatry, 6, 150, 2001.
98. Fatemi, S.H., Stary, J.M., and Egan, E.A., Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder, Cell. Mol., Neurobiol., 22, 139, 2002.
99. Ignatova, N., Sindic, C.J.M., and Goffinet, A.M., Characterization of the various forms of the Reelin protein in the cerebrospinal fluid of normal subjects and in neurological diseases, Neurobiol. Dis., 15, 326, 2004.
100. Liu, W.S. et al., Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse, Proc. Natl. Acad. Sci. USA, 98, 3477, 2001.
101. Tueting, P. et al., The phenotypic characteristics of heterozygous reeler mouse, Neuroreport, 10, 1329, 1999.
102. Tremolizzo, L. et al., An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability, Proc. Natl. Acad. Sci. USA, 99, 17095, 2002.
103. Groves, J.O. et al., Evaluation of the heterozygous reeler mouse as a potential model for schizophrenia, J. Psychopharmacol., 17, A43, 2003.
104. Salinger, W.L., Ladrow, P., and Wheeler, C., Behavioral phenotype of the reeler mutant mouse: effects of RELN gene dosage and social isolation, Behav. Neurosci., 117, 1257, 2003.
105. Podhorna, J. and Didriksen, M., The heterozygous reeler mouse: behavioral phenotype, Behav. Brain Res., 153, 43, 2004.
106. Hadj-Sahraoui, N. et al., Gender effect on Purkinje cell loss in the cerebellum of the heterozygous reeler mouse, J. Neurogenet., 11, 45, 1996.
107. Miller, M.T. et al., Autism associated with conditions characterized by developmental errors in early embryogenesis: a mini review, Int. J. Dev. Neurosci., 23, 201, 2005.
108. Arndt, T.L., Stodgell, C.J., and Rodier, P.M., The teratology of autism, Int. J. Dev. Neurosci., 23, 189, 2005.
109. Vorhees, C.V., Weisenburger, W.P., and Minck, D.R., Neurobehavioral teratogenic effects of thalidomide in rats, Neurotoxicol. Teratol., 23, 255, 2001.
110. Miyahara, T. et al., Autism model rat: marked behavioral changes in the embryonal thalidomide/valproic acid exposed rats, Program No. 318.8, Abstract Viewer/Itinerary Planner, Washington, D.C., Society for Neuroscience, 2003.
111. Narita, N. et al., Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism, Pediatr. Res., 52, 576, 2002.
112. Miyazaki, K., Narita, N., and Narita, M., Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism, Int. J. Dev. Neurosci., 23, 287, 2005.
113. Teitelbaum, P., A proposed primate animal model of autism, Eur. Child Adolesc. Psychiatry, 12, 48, 2003.
114. Ingram, J.L. et al., Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism, Neurotoxicol. Teratol., 22, 319, 2000.
115. Rodier, P.M. et al., Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei, J. Comp. Neurol., 370, 247, 1996.
116. Rodier, P.M., Converging evidence for brain stem injury in autism, Dev. Psychopathol., 14, 537, 2002.
117. Schneider, T. and Przewtocki, R., Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism, Neuropsychopharmacology, 30, 80, 2005.
118. Brost, D.R., Cross, J.D., and Hollerman, J.R., Social recognition memory following prenatal valproic acid: an animal model of autism, Abstract Viewer/Itinerary Planner, Washington, D.C.: Society for Neuroscience, 318, 10, 2003.
119. Hao, Y. et al., Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis, J. Neurosci., 24, 6590, 2004.
120. Costa, L.G. et al., Developmental neuropathology of environmental agents, Annu. Rev. Pharmacol. Toxicol., 44, 87, 2004.
121. Bennett, G.D. et al., Valproic acid-induced alterations in growth and neurotrophic factor gene expression in murine embryos, Reprod. Toxicol., 14, 1, 2000.
122. Faiella, A. et al., A mouse model for valproate teratogenicity: parental effects, homeotic transformation, and altered HOX expression, Hum. Mol. Genet., 9, 227, 2000.
123. Finnell, R.H. et al., Molecular basis of environmentally induced birth defects, Annu. Rev. Pharmacol. Toxicol., 42, 181, 2002.
124. Carpenter, E.M. et al., Loss of HOX-A1 (HOX-1.6) function results in the reorganization of the murine hindbrain, Development, 118, 1063, 1993.
125. Mark, M. et al., Two rhombomeres are altered in Hoxa-1 mutant mice, Development, 119, 319, 1993.
126. Ciaranello, A.L. and Ciaranello, R.D., The neurobiology of infantile autism, Annu. Rev. Neurosci., 18, 101, 1995.
127. Chess, S., Follow-up report on autism in congenital-rubella, J. Autism Child. Schizophr., 7, 69, 1977.
128. Brown, A.S. and Susser, E.S., In utero infection and adult schizophrenia, Ment. Retard. Dev. Disabil. Res. Rev., 8, 51, 2002.
129. Brown, A.S. et al., Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring, Am. J. Psychiatry, 161, 889, 2004.
130. Brown, A.S. et al., Serologic evidence of prenatal influenza in the etiology of schizophrenia, Arch. Gen. Psychiatry, 61, 774, 2004.
131. Shi, L., Fatemi, S.H., Sidwell, R.W., and Patterson, P.H., Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring, J. Neurosci., 23, 297, 2003.
132. Patterson, P.H. and Shi, L., Maternal influenza virus infection causes a cerebellar defect resembling that in autism, Int. Meeting. Autism Res., S3.3.4, 2002
133. Fatemi, S.H. et al., Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia, Cell. Mol. Neurobiol., 22, 25. 2002.
134. Fatemi, S.H. et al., Differential expression of synaptosome-associated protein 25 kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero, Brain Res., 800, 1, 1998.
135. Fatemi, S.H. et al., Prenatal viral infection causes alterations in nNOS expression in developing mouse brains, Neuroreport., 11, 1493, 2000.
136. Shi, L., Tu, N., and Patterson, P.H., Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus, Int. J. Dev. Neurosci., 23, 299, 2005.
137. Aronsson, F. et al., Persistence of viral RNA in the brain of offspring to mice infected with influenza A/WSN/33 virus during pregnancy, J. Neurovirol., 4, 353, 2003.
138. Meyer, U., Feldon, J., Schedlowski, M., and Yee, B.K., Towards an immunoprecipitated neurodevelopmental animal model of schizophrenia, Neurosci. Biobehav. Rev., 29, 913, 2005.
139. Zuckerman, L., Rehavi, M., Nachman, R., and Weiner, I., Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia, Neuropsychopharmacology, 28, 1778, 2003.
140. Borrell, J. et al., Prenatal immune challenge disrupts sensorimotor gating in adult rats: implications for the etiopathogenesis of schizophrenia, Neuropsychopharmacology, 36, 204, 2002.
141. Vargas, D.L. et al., Neuroglial activation and neuroinflammation in the brain of patients with autism, Ann. Neurol., 57, 67, 2005.
142. Fortier, M.E., Joober, R., Luheshi, G.N., and Boksa, P., Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring, J. Psychiatr. Res., 38, 335, 2004.
143. Dantzer, R., Cytokine-induced sickness behavior: a neuroimmune response to activation of innate immunity, Eur. J. Pharmacol., 500, 399, 2004.
144. Patterson, P.H., Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness, Curr. Opin. Neurobiol., 12, 115, 2002.
145. Fidel, P.L. et al., Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice, Am. J. Obstet. Gynecol., 170, 1467, 1994.
146. Urakubo, A., Jarskog, L.F., Lieberman, J.A., and Gilmore, J.H., Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain, Schizophr. Res., 47, 27, 2001.
147. Buka, S.L. et al., Maternal cytokine levels during pregnancy and adult psychosis, Brain Behav. Immun., 4, 411, 2001.
148. Lang, B., Dale, R.C., and Vincent, A., New autoantibody disorders of the central nervous system, Curr. Opin. Neurol., 16, 351, 2003.
149. Snider, L.A., and Swedo, S.E., PANDAS: current status and directions for research, Mol. Psychiatry, 9, 900, 2004.
150. Dalton, P. et al., Maternal neuronal antibodies associated with autism and a language disorder, Ann. Neurol., 53, 533, 2003.
151. Krause, I. et al., Brief report: immune factors in autism: a critical review, J. Autism. Dev. Disord., 32, 337, 2002.
152. Comi, A.M. et al., Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism, J. Child. Neurol., 14, 388, 1999.
153. Sweeten, T.L. et al., Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders, Pediatrics, 112, 420, 2003.
154. Hornig, M., Briese, T., and Lipkin, W.I., Borna disease virus, J. Neurovirol., 9, 259, 2003.
155. Pletnikov, M.V. et al., Effects of genetic background on neonatal Borna disease virus infection-induced neurodevelopmental damage. I. Brain pathology and behavioral deficits, Brain Res., 944, 97, 2002.
156. Dietz, D.M. et al., Developmental alterations in serotoninergic neurotransmission in Borna disease virus (BDV)-infected rats: a multidisciplinary analysis, J. Neurovirol., 5, 267, 2004.
157. Yamashita, Y. et al., Possible association between congenital cytomegalovirus infection and autistic disorder, J. Autism Dev. Disord., 33, 455, 2003.
158. Madsen, K.M. and Vestergaard, M., MMR vaccination and autism: what is the evidence for a causal association? Drug Saf., 27, 831, 2004.
159. Smeeth, L. et al., MMR vaccination and pervasive developmental disorders: a case control study, Lancet, 11, 963, 2004.
160. Hornig, M., Chian, D., Lipkin, W.I., Neurotoxic effects of postnatal thimerosal are mouse strain dependent, Mol. Psychiatry, 9, 833, 2004.
161. Parker, S.K., Schwartz, B., Todd, J., and Pickering, L.K., Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data, Pediatrics, 114, 793, 2004.
162. Andrews, N. et al., Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association, Pediatrics, 114, 584, 2004.
163. Critchley, H.D. et al., The functional neuroanatomy of social behavior: changes in cerebral blood flow when people with autistic disorder process facial expressions, Brain, 123, 2203, 2000.
164. Schultz, R.T. et al., The role of the fusiform face area in social cognition: implications for the pathobiology of autism, Philos. Trans. R. Soc. Lond. B Biol. Sci., 358, 415, 2003.
165. Howard, H.A. et al., Convergent neuroanatomical and behavioral evidence of an amygdala hypothesis of autism, Neuroreport, 11, 2931, 2000.
166. Davidson, R.J. and Slagter, H.A., Probing emotion in the developing brain: functional neuroimaging in the assessment of the neural substrates of emotion in normal and disordered children and adolescents, Ment. Retard. Dev. Disabil. Res. Rev., 6, 166, 2000.
167. Amaral, D.G., Bauman, M.D., and Mills Schumann, C., The amygdala and autism: implications from non-human primate studies, Genes Brain Behav., 2, 295, 2003.
168. Schumann, C.M. et al., The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages, J. Neurosci., 24, 6392, 2004.
169. Bachevalier, J., The amygdala, social cognition, and autism, in Aggleton, J.P. (Ed.), The Amygdala: a Functional Analysis, Oxford University Press, New York, 2000, p. 509.
170. Machado, C.J. and Bachevalier, J., Non-human primate models of childhood psychopathology: the promise and the limitations, J. Child Psychol. Psychiatry, 44, 64, 2003.
171. Amaral, D.G. and Corberr, B.A., The amygdala, autism and anxiety, Novartis Found. Symposium, Wiley, Chichester, U.K., 251, 177, 2003.
172. Prather, M.D. et al., Increased social fear and decreased fear of objects in monkeys with neonatal lesions, Neuroscience, 106, 653, 2001.
173. Wolterink, G. et al., Early amygdala damage in the rat as a model for neurodevelopmental psychopathological disorders, Eur. Neuropsychopharmacol., 11, 51, 2001.
174. Diergaarde, L. et al., Neonatal amygdala lesions and juvenile isolation in the rat: differential effects on locomotor and social behavior later in life, Behav. Neurosci., 118, 298, 2004.
175. Hall, F.S., Social deprivation of neonatal, adolescent, and adult rats has distinct neurochemical and behavioral consequences, Crit. Rev. Neurobiol., 12, 129, 1998.
176. Sarna, J.R. and Hawkes, R., Patterned Purkinje cell death in the cerebellum, Prog. Neurobiol., 70, 473, 2003.
177. Bobee, S., Mariette, E., Tremblay-Leveau, H., and Caston, J., Effects of early midline cerebellar lesion on cognitive and emotional functions in the rat, Behav. Brain Res., 112, 107, 2000.
178. Lev-Ram, V. et al., A novel non-ataxic guinea pig strain with cerebrocortical and cerebellar abnormalities, Brain Res., 606, 325, 1993.
179. Caston, J. et al., An animal model of autism: behavioral studies in the GS guineapig, Eur. J. Neurosci., 10, 2677, 1998.
180. Gerlai, R., Millen, K.J., Herrup, K., Fabien, K., Joyner, A.L., and Roder, J., Impaired motor learning performance in cerebellar EN-2 mutant mice, Behav. Neurosci., 110, 126, 1996.
181. Croen, L.A., Grether, J.K., Yoshida, C.K., Odouli, R., and Van de Water, J., Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders, Arch. Pediatr. Adolesc. Med., 159, 151, 2005.